If you use 'Compose Evaluation' or 'Dissent' to enter the details of your selected paper, then the easiest way to specify the paper is either to enter its PubMed ID number (PMID) or its digital object identifier (DOI).

a) The PMID can be found in each PubMed listing as follows:

b) The DOI is a permanent identifier for an article that does not change with time. Most major publishers assign a unique DOI to each of their articles, displaying them on the website and in print. For more details, see www.doi.org.

Alternatively, you can enter as many details as you know and we will try to find a match in PubMed. You also have the option to evaluate a paper that is not yet or likely never to be in PubMed.

For each selected paper, you will need to write a comment, and then rate, classify, and categorize it.

2-4 sentences explaining why you found the paper interesting. Our aim is to make the first sentence intelligible to a wide biology readership and to have it convey why this paper is noteworthy. The second sentence can provide more specialist information. Additional sentences are optional but please keep the comments brief.
For example:

"This paper upsets the conventional assumption that activation of the Notch pathway depends on binding of ligands to the Notch extracellular domain and suggests that in some cells Notch2 might be constitutively active. The coding region of the Notch2 mRNA is shown to contain an Internal Ribosome Entry Site, positioned so as to allow direct production of the active intracellular portion of Notch2, without need of the usual ligand-triggered proteolytic cleavage."

There are three types; you need to pick one

• Recommended reading (of specialist interest)
• Must read (of general interest)
• Landmark paper representing top 1% of publications

There are five types; you can pick as many as you feel are relevant.

Novel finding
Technical advance
Interesting hypothesis
Important confirmation
Controversial findings

We ask that you assign your selected paper to the most relevant faculty sections (sometimes it may be only one section; other times it may be several). The relevant sections can be in different faculties. When you registered, we asked you to select the sections that you were most likely to use. You can alter these at any stage by going to My Details and clicking on Favorite sections.
For example, a paper on NGF signaling could be categorized as being relevant to "Neurodevelopment", "Neuronal and glial cell biology", "Neuronal signalling".
To see a description of what areas are covered within which F1000 Sections, go to Scope of Faculties and Sections in About F1000.

We ask that Faculty Members declare both 'Non-Financial' and 'Financial' Competing Interests that might lead a reasonable person to question their impartiality. For every submission (i.e. an evaluation or dissenting opinion) on which you select the "Competing interest to declare" option, you must provide details (in the textbox provided). If you are unsure whether you have a competing interest, please contact our editorial office (editorial@f1000biology.com).

It might be helpful to consider the following examples, but note that this is not an exhaustive list:

Examples of 'Non-Financial Competing Interests'
1) Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.
2) You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.
3) You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).
4) You hope/expect to benefit (e.g. favour or employment) as a result of your submission.
5) If submitting a Dissenting opinion: You have a longstanding disagreement with any of the authors.

Examples of 'Financial Competing Interests'
1) You expect to receive, or in the past 4 years have received, any of the following from commercial organizations that may gain financially from your submission: a salary, fees, funding or reimbursements.
2) You hold, or are currently applying for, any patents or significant stocks/shares relating to your submission.

If you don't have time to complete the evaluation process or want to simply save a draft, then you can move your draft evaluation and complete it later. All drafts are saved in Draft Evaluations in My Evaluations.